sevoflurane has been researched along with Disease Exacerbation in 6 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The inhaled sevoflurane (sevo) is known to protect against myocardial ischemia/reperfusion (I/R) injury (MIRI), in which the functions of microRNAs (miRNAs) have been uncovered." | 7.96 | Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1. ( Bai, TZ; Chen, XX; Li, ZF; Tan, DX; Zhang, J, 2020) |
| "The inhaled sevoflurane (sevo) is known to protect against myocardial ischemia/reperfusion (I/R) injury (MIRI), in which the functions of microRNAs (miRNAs) have been uncovered." | 3.96 | Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1. ( Bai, TZ; Chen, XX; Li, ZF; Tan, DX; Zhang, J, 2020) |
| "Amnestic mild cognitive impairment (aMCI) is thought to be a transitional stage between normal aging and the development of Alzheimer's disease (AD)." | 2.78 | Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study. ( Gao, M; Guo, W; Li, H; Liu, G; Liu, Y; Ma, Y; Pan, N; Zhang, S; Zhou, J, 2013) |
| "In conclusion, sevoflurane inhibited colon cancer progression by modulating the exosome‑transmitted circ‑HMGCS1/miR‑34a‑5p/SGPP1 axis." | 1.56 | Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome‑mediated circ‑HMGCS1 via the miR‑34a‑5p/SGPP1 axis. ( Ai, Y; He, J; Liu, X; Wang, D; Wang, Y; Yang, J; Zhao, H, 2020) |
| "Sevoflurane is a general anesthetic commonly used in the pediatric setting because it is sweet-smelling, nonflammable, fast acting and has a very short recovery time." | 1.39 | Early life exposure to sevoflurane impairs adulthood spatial memory in the rat. ( Guo, X; Liu, Y; Shen, R; Shen, X; Wang, F; Xu, S; Zhao, Q, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X | 1 |
| Peng, Y | 1 |
| Shen, J | 1 |
| Yang, L | 1 |
| Tan, DX | 1 |
| Chen, XX | 1 |
| Bai, TZ | 1 |
| Zhang, J | 1 |
| Li, ZF | 1 |
| He, J | 1 |
| Zhao, H | 1 |
| Liu, X | 1 |
| Wang, D | 1 |
| Wang, Y | 1 |
| Ai, Y | 1 |
| Yang, J | 1 |
| Shen, X | 1 |
| Liu, Y | 2 |
| Xu, S | 1 |
| Zhao, Q | 1 |
| Guo, X | 1 |
| Shen, R | 1 |
| Wang, F | 1 |
| Pan, N | 1 |
| Ma, Y | 1 |
| Zhang, S | 1 |
| Guo, W | 1 |
| Li, H | 1 |
| Zhou, J | 1 |
| Liu, G | 1 |
| Gao, M | 1 |
| Barbry, T | 1 |
| Le Guen, M | 1 |
| De Castro, V | 1 |
| Coriat, P | 1 |
| Riou, B | 1 |
| Vivien, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neurodevelopment Outcomes After Pediatric Dental Caries Treatment Under General Anaesthesia[NCT03002792] | 360 participants (Anticipated) | Observational | 2017-01-31 | Not yet recruiting | |||
| Evaluation of Neurotoxic Effect of Sevoflurane-Based Anaesthesia Guided by Significant Short-Term Olfactory Identification Impairment in Old Age[NCT03726580] | 600 participants (Actual) | Observational [Patient Registry] | 2017-03-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sevoflurane and Disease Exacerbation
| Article | Year |
|---|---|
Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study.
Topics: Administration, Inhalation; Aged; Amnesia; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; | 2013 |
5 other studies available for sevoflurane and Disease Exacerbation
| Article | Year |
|---|---|
Sevoflurane inhibits progression of glioma via regulating the HMMR antisense RNA 1/microRNA-7/cyclin dependent kinase 4 axis.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase 4; Disease Progre | 2021 |
Sevoflurane up-regulates microRNA-204 to ameliorate myocardial ischemia/reperfusion injury in mice by suppressing Cotl1.
Topics: Anesthetics, Inhalation; Animals; Disease Progression; Hemodynamics; Male; Mice; Mice, Inbred C57BL; | 2020 |
Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome‑mediated circ‑HMGCS1 via the miR‑34a‑5p/SGPP1 axis.
Topics: Aged; Animals; Apoptosis; Case-Control Studies; Cell Line, Tumor; Cell Movement; Cell Survival; Colo | 2020 |
Early life exposure to sevoflurane impairs adulthood spatial memory in the rat.
Topics: Age Factors; Analysis of Variance; Anesthetics, Inhalation; Animals; Animals, Newborn; Developmental | 2013 |
Early life exposure to sevoflurane impairs adulthood spatial memory in the rat.
Topics: Age Factors; Analysis of Variance; Anesthetics, Inhalation; Animals; Animals, Newborn; Developmental | 2013 |
Early life exposure to sevoflurane impairs adulthood spatial memory in the rat.
Topics: Age Factors; Analysis of Variance; Anesthetics, Inhalation; Animals; Animals, Newborn; Developmental | 2013 |
Early life exposure to sevoflurane impairs adulthood spatial memory in the rat.
Topics: Age Factors; Analysis of Variance; Anesthetics, Inhalation; Animals; Animals, Newborn; Developmental | 2013 |
Minimum alveolar concentration of halogenated volatile anaesthetics in left ventricular hypertrophy and congestive heart failure in rats.
Topics: Anesthetics, Inhalation; Animals; Disease Progression; Dose-Response Relationship, Drug; Halothane; | 2007 |